Jefferies has downgraded SRF to an underperform rating, citing weak Q2 results.
Jefferies has cut its target price to ₹2,070, implying a 6.0% downside from the current market price of ₹2,203.90. The brokerage noted that inventory destocking in the chemical segment led to the underperformance, and while management is optimistic about H2, Jefferies remains cautious.
With a projected downside, Jefferies’ outlook suggests SRF might be a stock to sell.
Disclaimer: The information provided is for informational purposes only and should not be construed as investment advice.
